Heterogeneous Distribution of Tumor Blood Supply Affects the Response to Chemotherapy in Patients with Head and Neck Cancer

References

• Acker J, Dewhirst M, Honore G, Sarnulski T, Tucker J, Oleson J. (1990). Blood perfusion measurements in human tumours: Evaluation of laser doppler meth-ods. Int J Hypertermia 6:287–304.
   Google Scholar
• Alton P, Harris A. (1993). The role of DNA topoi-somerases II in drug resistance. Br J Haematol 85: 241–245.
   PubMed Web of Science ®Google Scholar
• Baish J, Gazit Y, Berk D, Nozue M, Baxter L, Jain RK. (1996). A novel approach to examine the role of vas-cular heterogeneity in nutrient and drug delivery for tumors: An invasion percolation model. Microvasc Res 51:327–346.
   PubMedGoogle Scholar
• Boucher Y, Brekken C, Netti PA, Baxter LT, Jain RK. (1998). Intraturnoral infusion of fluid: Estimation of hydraulic conductivity and implications for the deliv-ery of therapeutic agents. Br J Cancer 78:1442–1448.
   PubMed Web of Science ®Google Scholar
• Burt R, Fojo A, Thorgeirsson S. (1990). 1VIultidrug re-sistance due to P-glycoprotein. Hosp Pract 25:51–61.
   Google Scholar
• Curd B, Smith JW. (1992). Physiological barriers to drug delivery in tumors. Clin Oncol Alert Sept:70–72.
   Google Scholar
• Dvorak H, Nagy J, Dvorak J, Dvorak A. (1988). Iden-tification and characterization of the blood vessels of solid tumors that are leaky to circulating macromol-ecules. Am J Pathol 133:95–109.
   PubMed Web of Science ®Google Scholar
• Eskey C, Koretsky A, Domach M, Jain RK. (1992). 2H-nuclear magnetic resonance imaging of tumor blood flow: Spatial and temporal heterogeneity in a tissue-isolated mammary carcinoma. Cancer Res 52: 6010–6019.
   PubMed Web of Science ®Google Scholar
• Everitt BS. (1997). Multidimensional tables. In: The Analysis of Contingency Tables, 2nd edition. (BS Everitt BS, ed.) Chapman & Hall. London. p. 71.
   Google Scholar
• Everitt BS. (1997). Contingency tables with ordered categories. In: The Analysis of Contingency Tables, 2nd edition. (BS Everitt, ed.) Chapman & Hall. Lon-don. p. 130.
   Google Scholar
• Folkman J. (1986). The vascularization of tumors. In: Cancer Biology- Readings from Sci Am. (WH Freeman, ed.) WH Freeman and Co. New York. pp. 114–124.
   Google Scholar
• Folkman J. (1995). Tumor angiogenesis. In: The Mo-lecular Basis of Cancer. (P Mendelsohn, M Howley, L Liotta, eds.) WB Saunders. Philadelphia. pp. 206–232.
   Google Scholar
• Galmarini CM, Galmarini FC. (1998). Intraarterial chemotherapy as an orthotopic in vivo model to study heterogeneous distribution of blood supply in human cancers. In: XXXI World Congress of the International College of Surgeons. (R Almasque� Dedeu, M Padorno, C Linares, E Hurtado Hoyo, F Ortiz, P Giordano, eds.) Monduzzi Editori. Bologna. pp. 51�54.
   Google Scholar
• Galmarini FC. (1979). U.S. NCI�OSITC workshop on intraarterial chemotherapy in head and neck cancer. Rev Sud Onco 3:11�12.
   Google Scholar
• Galmarini FC. (1979). Does cancer rising in the oral cavity curatively respond to single modality? Chemotherapeutic approach. In: Advances in Medical Oncology, Research and Education�Clinical Cancer Vol XI. (PM Wilkinson, ed.) Pergamon Press. New York. pp. 185�196.
   Google Scholar
• Galmarini F, Abulafia J, Galmarini CM. (1997). Heterogeneous nature of tumor vascularization affects the therapeutic response to chemotherapy in patients with advanced head and neck cancer. Proc Am Soc Clin Oncol 16:551a (abstr).
   Google Scholar
• Galmarini FC, Yoel J, Nakasone J, Coni Molina C. (1985). Intraarterial association of cis-platin and bleomycin in head and neck cancer. Auris Nasus Larynx a12:234�238.
   Google Scholar
• Goldie J, Coldman A. (1985). Genetic instability in the development of drug resistance. Semin Oncol 12: 222�230.
   Google Scholar
• Grau C, Overgaad J. (1988). Effect of cancer chemo-therapy on the hypoxic fraction of a solid tumor mea-sured using a local tumor control assay. Radiother Oncol 13:301–309.
   PubMed Web of Science ®Google Scholar
• Griffon-Etienne G, Boucher Y, Brekken C, Suit HD, Jain RK. (1999). Taxane-induced apoptosis decom-presses blood vessels and lowers interstitial fluid pres-sure in solid tumors: Clinical implications. Cancer Res 59:3776–3782.
   PubMed Web of Science ®Google Scholar
• Jain RK. (1988). Determinants of tumor blood flow: A review. Cancer Res 48:2641–2658.
   PubMedGoogle Scholar
• Jain RK. (1989). Delivery of novel therapeutic agents in tumors: Physiological barriers and strategies. J Natl Cancer Inst 81:570–576.
   Google Scholar
• Jain RK. (1994). Barriers to drug delivery in solid
   Google Scholar
• Jain RK. (1997). Delivery of molecular and cellular medicine to solid tumors. Microcirculation 4:3–23.
   Google Scholar
• Jain RK. (1998). The next frontier of molecular medi-
   Google Scholar
• Jain RK. (1999). Understanding barriers to drug de-livery: High resolution in vivo imaging is key. Clin Cancer Res 5:1605–1606.
   Google Scholar
• Jain RK, Baxter L. (1988). Mechanism of heterogeneous distribution of monoclonal antibodies and other macro-molecules in tumors: Significance of elevated interstitial pressure. Cancer Res 48:7022–7032.
   PubMed Web of Science ®Google Scholar
• Jedlitschky G, Leier Y, Buchholz U, Barnoyin K, Kurz G, Dietrich K. (1996). Transport of glutathion, glu-coronate and sulfate conjugates by the MRP gene en-coded export pump. Cancer Res 56:988–994.
   PubMed Web of Science ®Google Scholar
• Kolatag A. (1986). Why do cancer cells resist drugs? Science 231:220–221.
   Google Scholar
• Kristensen CA, Roberge S, Jain RK. (1997). Effect of tumor necrosis factor alpha on vascular resistance, nitric oxide production, and glucose and oxygen con-sumption in perfused tissue-isolated human mela-noma xenografts. Clin Cancer Res 3:319–324.
   PubMed Web of Science ®Google Scholar
• Kristjansen P, Roberge S, Lee Y, Jain RK. (1994). Tissue-isolated human tumor xenografts in athymic nude mice. Microvasc Res 48:389–402.
   PubMed Web of Science ®Google Scholar
• Less J, Skalak T, Sevick E, Jain RK. (1991). Micro-vascular architecture in a mammary carcinoma: Branching patterns and vessel dimensions. Cancer Res 51:265–73.
   PubMed Web of Science ®Google Scholar
• Less J, Posner M, Skalak T, Wolrnark N, Jain RK. (1997). Geometric resistance to blood flow and vas-cular network architecture in human colorectal car-cinoma. Microcirculation 4:25–33.
   PubMed Web of Science ®Google Scholar
• Mattson J, Peterson H. (1981). Influence of vasoactive drugs on tumor blood flow. Anticancer Res 1:59–61.]
   Web of Science ®Google Scholar
• Nati PA, Hamberg LM, Babich JW, Kierstead D, Gra-ham W, Hunter GJ, Wolf GL, Fischman A, Boucher Y, Jain RK. (1999). Enhancement of fluid filtration across tumor vessels: Implication for delivery of macromol-ecules. Proc Natl Acad Sci USA 96:3137–3142.
   Google Scholar
• Puppo C, Claros S, Martinez H, Galmarini FC. (1982). Local perfusion of cytostatic agents in the treatment of tumors of the limbs. US NCI Oncol Over-view Sept:341 (abstr).
   Google Scholar
• Scheffer G, Wijngaard P, Flens M, Izquierdo M, Slo-vak M, Pinedo H. (1995). The drug resistance related protein LRP is the human major vault protein. Na-ture Med 1:578–582.
   PubMed Web of Science ®Google Scholar
• Sevick E, Jain RK. (1988). Geometric resistance to blood flow in solid tumors perfused ex vivo: Effects of tumor size and perfusion pressure. Cancer Res 48: 1201–1207.
   PubMedGoogle Scholar
• Sevick E, Jain RK. (1989). Viscous resistance to blood flow in solid tumors: Effect of hematocrit on intraturnor blood viscocity. Cancer Res 49:3513–3519.
   PubMed Web of Science ®Google Scholar
• Sevick E, Jain RK. (1991). Effect of red blood cell rigidity on tumor blood flow: Increase in viscous resistance during hyperglycemia. Cancer Res 49:3513–3519.
   Google Scholar
• Vaupel P, Kallinowski F, Okunieff P. (1989). Blood flow, oxygen and nutrient supply, and metabolic en-viroment of human tumors: A review. Cancer Res 49: 6449–6465.
   PubMed Web of Science ®Google Scholar
• Yoel J, Galrnarini FC. (1972). Chirurgie et perfusions regionales d'agents cytostatiques dans be traitement du cancer de la tete et du cou. Gazzetta Sanitaria 31:31–38.
   Google Scholar